category,datetime,headline,id,image,related,source,summary,url
company,1768573620,3 Undervalued Medical Instrument Stocks Poised to Grow in 2026,138152786,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,STE,Yahoo,"FMS, IART and STE trade below historical valuations. Easing cost pressure and improved execution set the stage for potential upside in 2026 for these companies.",https://finnhub.io/api/news?id=59e88f30cb5e8dbc12f2dd56b6daa5edda4b634524310e88ac59bb5af3498827
company,1768538175,1 Mid-Cap Stock for Long-Term Investors and 2 Facing Challenges,138152787,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,STE,Yahoo,"Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. However, they face intense competition from scaled industry giants and can be disrupted by new innovative players vying for a slice of the pie.",https://finnhub.io/api/news?id=4f9a7096f35ec5adfb275bb4eb8f1820501496a671752b208b2064121f0872f9
company,1768529371,Will STERIS' (STE) Standout Revenue Beat and Peer-Leading Growth Shift Its Core Investment Narrative?,138147516,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,STE,Yahoo,"STERIS recently reported a very strong quarter, with revenue rising 9.9% year on year and coming in 2% above analyst expectations, marking the fastest growth and biggest estimates beat among its peer group. This performance underlines the companyâ€™s mission-critical role in infection prevention, where its sterilization products and services support healthcare facilities and life science customers that rely on uninterrupted operations. We'll now examine how STERIS's stronger-than-expected...",https://finnhub.io/api/news?id=87c8ffe6489846a6ea6d318c651cad00b1d717fd0cac93728e9d81a152c8b233
